Pharmacotherapy in the Public Sector Care of Hispanics

  • George L. Adams
  • Rosalind J. Dworkin
  • Sandra D. Roserberg


It is believed that the unique characteristics of Hispanics, rooted in their cultural heritage, play a major role in their utilization of mental health services and response to pharmacotherapeutic treatment (1,2). Moreover, it is believed that the Hispanic patient seen in the public sector typically suffers from a major psychiatric disorder. Epidemiological studies have suggested that the poor, including Hispanics, are more often labeled as being severely mentally disordered, and that the Hispanic population suffers a higher incidence of major psychiatric disorder than the general population (3,4). Some studies report that there are more Hispanics who have functionally impairing symptomatology compared to other persons who are mentally ill (4,5). Still other research has shown that low income, poorly educated patients, Hispanics included, are accepted less often into psychotherapy (7). Furthermore, low income groups generally receive less physician time than more affluent groups (8), and are more likely to be on chemotherapy (7). Thus the public sector mental health care network is most often the primary point of access for Hispanics who require mental health services in the United States, and pharmacotherapy is considered to be an integral part of the treatment plan for the Hispanic patient.


Mental Health Service Hispanic Patient Major Psychiatric Disorder Affluent Group Multiple Classification Analysis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Edgerton, R.B. and Karno, M., Mexican-American bilingualism and the perception of mental illness, Arch Gen Psychiat 24:286–290 (1971).PubMedCrossRefGoogle Scholar
  2. 2.
    Kline, L.Y., Some factors in the psychiatric treatment of Spanish Americans, Arn J Psychiat, 125:1674–1681 (1969).Google Scholar
  3. 3.
    Dohrenwend, B.P., Social class and culture influences on pyschopathology, Ann Reve Psychol, 25:417–452 (1974).CrossRefGoogle Scholar
  4. 4.
    Srole, L., Langner, T.S., Michael, S.T., Opler, M.K., and Rennie, T.A.C., “Mental Health in the Metropolis: The Midtown Manhattan Study, Mc-Graw Hill, New York (1962).CrossRefGoogle Scholar
  5. 5.
    Haberman, P.W., Ethnic differences in psychiatric symptom in community surveys, Public Health Rep 84:495 (1970).Google Scholar
  6. 6.
    Yamamoto, J., James, O.C., Bloombaum, M., and Hattem, J., Racial factors in patient selection, Am J Psychiat, 124: 630–636 (1967).PubMedGoogle Scholar
  7. 7.
    Hollingshead, A.B., and Redlich, F.C., “Social Class and Mental Illness: A Community Study,” John Wiley and Sons, New York (1958).CrossRefGoogle Scholar
  8. 8.
    U.S. Department of Health, Education, and Welfare: Health Status of Minorities and Low-Income Groups. Public Health Service Publication No. HRA 79–627. U.S. Government Printing Office, Washington, D.C. (1978).Google Scholar
  9. 9.
    Karno, M., Ross, R.N., and Caper, R.A., Mental health roles of physicians in a Mexican-American community, Community Ment Health J, 5:62–69 (1969).CrossRefGoogle Scholar
  10. 10.
    Acosta, F.S., Ethnic variables in psychotherapy: the Mexican-American, in: “Chicano Psychology,” J.L. Martinez, ed., Academic Press, New York (1977).Google Scholar
  11. 11.
    Yamamoto, J., and Acosta, F.X., Treatment of Asian Americans and Hispanic Americans: similarities and differences, J Am Acad Psychoanal, 10:585–607 (1982).PubMedGoogle Scholar
  12. 12.
    Ziegler, V.E., and Biggs, J.T., Tricyclic plasma levels: effects of age, race, sex, and smoking, JAMA 238:2167 (1977).PubMedCrossRefGoogle Scholar
  13. 13.
    Raskin A., and Crook, T.H., Antidepressants in black and white inpatients, Arch Gen Psychiat, 32:643 (1975).PubMedCrossRefGoogle Scholar
  14. 14.
    Overall, J.E., Hollister, L.E., Kimbell, I., and Shelton, L., Extrinsic factors influencing responses to psychotherapeutic drugs, Arch Gen Psychiat, 21:89 (1969).PubMedCrossRefGoogle Scholar
  15. 15.
    Murphy, H.B.M., Ethnic variations in drug response: results of an international survey, Transcult Psychiat Res, 6: 5–23 (1969).CrossRefGoogle Scholar
  16. 16.
    Marcos, L.R., and Cancro, R., Pharmacotherapy on Hispanic depressed patients: clinical observations, Am J Psychother, 36:505–512 (1982).PubMedGoogle Scholar
  17. 17.
    Davis, J.M., Dose equivelance antipsychotic drugs, J Psychiat Res, 11:65–69 (1974).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • George L. Adams
    • 1
  • Rosalind J. Dworkin
    • 1
  • Sandra D. Roserberg
    • 1
  1. 1.Community and Social Psychiatry Programs Baylor College of MedicineTexas Medical CenterHoustonUSA

Personalised recommendations